Related Experiment Video
Updated: Feb 19, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
Published on: January 26, 2018
[Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis]
Anxo Fernández-Ferreiro1, Andrea Luaces-Rodríguez2, Victoria Díaz-Tomé3
1Servicio de Farmacia, Xerencia Xestión Integrada Santiago de Compostela (SERGAS) Grupo Farmacología Clínica, Instituto de Investigación Sanitaria, Santiago de Compostela (IDIS-ISCIII) Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela (USC). anxordes@gmail.com.
Abstract:
Ocular cystinosis is a rare disease characterised by the deposit of cystine crystals on the corneal surface, which hinder patients' eyesight. Oral cysteamine is given as cysteamine; however, it does not reach the cornea due to the lack of corneal vascularization making necessary its administration by the topical ocular route. The aim of the present study is to determine the stability of an ophthalmic hydrogel of cysteamine, which can be potentially prepared at hospital pharmacy departments, under different preservation conditions during a follow-up of 30 days. Different physical and chemical parameters were evaluated: osmolality, pH and cysteamine concentration, which has been measured by a method of ultra performance liquid chromatography-tandem mass spectrometer (UPLC-MS/MS). Descriptive assays were also performed, such as transparency measurement and microbiological assays in order to verify its sterility. The obtained results allow us to conclude that the cysteamine hydrogel is stable during 30 days, being recommendable its preservation in refrigerated conditions.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Cystic Fibrosis: Management
Sinus disease and chronic...
Urologic Endoscopic Procedure: Cystoscopic Examination
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Direct-Acting Cholinergic Agonists: Therapeutic Uses

